Biotech | February 25, 2022
Actu-Real and Jehangir Clinical Dev Centre announce strategic collaboration
The joint initiative is called J-ARC Healthcare Solutions
The joint initiative is called J-ARC Healthcare Solutions
Jardiance is the first and only heart failure therapy to demonstrate a statistically significant risk reduction in cardiovascular death or hospitalization for heart failure, regardless of ejection fraction
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
100% efficacy against severe Covid-19 disease and hospitalizations
Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
Zydus unveils its ‘innovation and care’ centric corporate brand identity
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
Subscribe To Our Newsletter & Stay Updated
